These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 769721)

  • 21. Stimulant drug treatment of hyperactivity: biochemical correlates.
    Elia J; Borcherding BG; Potter WZ; Mefford IN; Rapoport JL; Keysor CS
    Clin Pharmacol Ther; 1990 Jul; 48(1):57-66. PubMed ID: 2196146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fenfluramine and dextroamphetamine treatment of childhood hyperactivity. Clinical and biochemical findings.
    Donnelly M; Rapoport JL; Potter WZ; Oliver J; Keysor CS; Murphy DL
    Arch Gen Psychiatry; 1989 Mar; 46(3):205-12. PubMed ID: 2645848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD.
    James RS; Sharp WS; Bastain TM; Lee PP; Walter JM; Czarnolewski M; Castellanos FX
    J Am Acad Child Adolesc Psychiatry; 2001 Nov; 40(11):1268-76. PubMed ID: 11699800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline.
    Pelham WE; Greenslade KE; Vodde-Hamilton M; Murphy DA; Greenstein JJ; Gnagy EM; Guthrie KJ; Hoover MD; Dahl RE
    Pediatrics; 1990 Aug; 86(2):226-37. PubMed ID: 2196522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 27. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults.
    Taylor FB; Russo J
    J Child Adolesc Psychopharmacol; 2000; 10(4):311-20. PubMed ID: 11191692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effects of lisdexamfetamine and mixed amphetamine salts immediate release in adult ADHD: results of a crossover design clinical trial.
    Adler LA; Alperin S; Leon T; Faraone S
    Postgrad Med; 2014 Sep; 126(5):17-24. PubMed ID: 25295646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis with focus on bupropion.
    Stuhec M; Munda B; Svab V; Locatelli I
    J Affect Disord; 2015 Jun; 178():149-59. PubMed ID: 25813457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lisdexamfetamine.
    Blick SK; Keating GM
    Paediatr Drugs; 2007; 9(2):129-35; discussion 136-8. PubMed ID: 17407369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hair zinc predict amphetamine improvement of ADD/hyperactivity?
    Arnold LE; Votolato NA; Kleykamp D; Baker GB; Bornstein RA
    Int J Neurosci; 1990 Jan; 50(1-2):103-7. PubMed ID: 2269593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letter: Stimulant drugs for problem children.
    N Engl J Med; 1973 Dec; 289(25):1375-6. PubMed ID: 4201792
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial.
    Efron D; Jarman F; Barker M
    Pediatrics; 1997 Dec; 100(6):E6. PubMed ID: 9382907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Managing ADHD in general practice. N of 1 trials can help!
    Duggan CM; Mitchell G; Nikles CJ; Glasziou PP; Del Mar CB; Clavarino A
    Aust Fam Physician; 2000 Dec; 29(12):1205-9. PubMed ID: 11140235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
    Weisler RH; Greenbaum M; Arnold V; Yu M; Yan B; Jaffee M; Robertson B
    CNS Drugs; 2017 Aug; 31(8):685-697. PubMed ID: 28712074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between computer-based testing and behavioral ratings in the assessment of attention and activity in a pediatric ADHD stimulant crossover trial.
    Ramtvedt BE; Sundet K
    Clin Neuropsychol; 2014; 28(7):1146-61. PubMed ID: 25249305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 40. Sleep amphetamine effects in MBDS and normal subjects.
    Feinberg I; Hibi S; Braun M; Cavness C; Westerman G; Small A
    Arch Gen Psychiatry; 1974 Nov; 31(5):723-31. PubMed ID: 4374157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.